Ph.D., Partner, McKinsey
Biography
Dr. The is a leader in our Life Sciences practice, where she serves biotechs and pharmacos on R&D strategy. She is also a leader in overall service line for high-growth biotech clients. She is a leader in McKinsey’s Center for Asset Optimization where she develop R&D strategy, for platform technologies, portfolios and individual assets. In the past ten years, she has developed portfolio and platform strategies for 20+ biopharma companies. Throughout her work, she focus on helping companies deliver transformational therapies to maximize patient benefit. She received her Ph.D. in Molecular & Cell Biology at UC Berkeley, where she studied the molecular mechanisms of atopic dermatitis and was supported by an NSF Graduate Research Fellowship.
Session Abstract – PMWC 2022 Silicon Valley
Track 2 - June 30 9.00 A.M.-10.15 A.M.
This session outlines current challenges and opportunities related to the use of AI to advance therapeutic development and care delivery, with a special focus on medical imaging.
